Reported 2 months ago
Investors seeking reliable income are encouraged to consider Pfizer and Ares Capital, both providing attractive dividend yields significantly above the S&P 500 average. Pfizer boasts a 5.5% yield backed by a solid track record of raising dividends, while Ares Capital offers a compelling 9.2% yield as a business development company focusing on lending to mid-sized firms. Holding these stocks could yield substantial passive income and potential capital appreciation over the next decade.
Source: YAHOO